People who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the Indian variant of SARS-CoV-2 , according to new UK data.
All seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will see whether they can be used as a third booster dose to protect against new variants.
A review of side effects reported with coronavirus vaccines by the EMA's safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty
Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.